A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
Clinical trial NCT00002185 · COMPLETED
Trial details
- NCT number
- NCT00002185
- Sponsor
- Agouron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.